The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

The ongoing trade conflict and increasing economic concerns weigh heavily on earnings expectations. Yet, forecasts for the US ...

Following the recent near-financial crash, calls to exclude US government bonds from banks’ capital ratios are growing louder ...

After Accelleron, ABB is preparing its next billion dollar IPO. The new CEO is making his mark and delivers good results.

Philip Morris shares have risen by more than 50% in the past twelve months – the transformation is going well. In an interview, European CEO Massimo Andolina explains why there is no longer a future ...

Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is considered highly recession-resistant. Anyone investing in the highly nervous US ...

Six investment professionals tell our readers how to navigate in view of new US trade barriers. Today Philipp Lienhardt, Head of Equity Research at Julius Baer, reveals his tips. «Finanz und ...

A Swiss financial centre initiative demands strict climate protection regulations for banks and insurers. UBS, Zurich ...